What Blood Tests Could Mean for Early Alzheimer’s Detection — Pre-recorded Webinar
Date & Time:
September 2
10:00 am - 11:00 am
Location: Holz Pavilion Theater
What Blood Tests Could Mean for Early Alzheimer’s Detection
Wednesday, September 2 | 10am – 11am | Holz Pavilion Theater
Blood tests and other biomarkers are bringing researchers closer to detecting Alzheimer’s disease before memory loss begins — a shift that could reshape prevention, treatment, and the way families think about risk. Dr. Joshua Grill, director of the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) and UCI’s NIA-funded Alzheimer’s Disease Research Center, explains how advances in amyloid PET scans, spinal fluid testing, and blood-based biomarkers are changing Alzheimer’s research and care. He also discusses why these tests are useful today for people already experiencing cognitive symptoms, why they are not yet recommended as a routine risk test for people without memory problems, and how biomarkers are helping researchers design prevention trials for people at higher biological risk. He also explained the emotional, ethical, and legal questions that come with assessing Alzheimer’s risk and what still needs to happen before early testing and treatment become part of routine care.
Questions? Contact: Jen Graf, Senior Director of Cognitive Health
262.965.7133 or Email: Jgraf@threepillars.org
